Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17366418 | 0.93 | HIF1A (0.33) | HIF1AMAPTPDE4AKDR | |
| SCHEMBL4140732 | 0.93 | — | — | |
| SCHEMBL44386 | 0.93 | — | — | |
| SCHEMBL5706376 | 0.86 | — | — | |
| Methane SCHEMBL16241315 | 0.86 | HIF1A (0.30) | HIF1AMAPTPDE4AKDR | |
| Ammonia Solution, Strong SCHEMBL27794312 | 0.86 | — | — | |
| SCHEMBL182191 | 0.84 | — | — | |
| Ethylene SCHEMBL28083938 | 0.80 | — | — | |
| SCHEMBL5616852 | 0.76 | HIF1A (0.50) | HIF1AMAPTPDE4AKDR | |
| SCHEMBL5852190 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617761-B2 | Process for producing hexahydro 1,3,5-trinitro-1,3,5-triazine and octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine | PHILLIPS JAMES E (US) | 2026-05-05 | — | — | US | claimed |
| US-20240300906-A1 | PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE | PHILLIPS JAMES E (US) | 2024-09-12 | — | — | US | claimed |
| US-20240228445-A9 | PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE | PHILLIPS JAMES E (US) | 2024-07-11 | — | — | US | claimed |
| US-20240132454-A1 | PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE | PHILLIPS JAMES E (US) | 2024-04-25 | — | — | US | claimed |
| EP-3468923-B1 | FLUORESCENT WATER TREATMENT COMPOUNDS AND METHOD OF USE | ECOLAB USA INC (US) | 2022-10-19 | — | — | EP | claimed |
| US-20200138787-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-05-07 | — | — | US | claimed |
| US-10292967-B2 | Compositions comprising corneoscleral tissue cross-linking agents | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-05-21 | — | — | US | claimed |
| US-20190015388-A1 | COMPOSITIONS COMPRISING CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-01-17 | — | — | US | claimed |
| US-10105350-B2 | Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking agents | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2018-10-23 | — | — | US | claimed |
| US-20160374992-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-12-29 | — | — | US | claimed |
| WO-2015138794-A9 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-03-31 | — | — | WO | claimed |
| US-20120046246-A1 | METHODS FOR TREATING OSTEOCLAST-RELATED DISEASE, COMPOUNDS AND COMPOSITIONS THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2012-02-23 | — | — | US | claimed |
| WO-2010071826-A2 | METHODS FOR TREATING OSTEOCLAST-RELATED DISEASE, COMPOUNDS AND COMPOSITIONS THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2010-06-24 | — | — | WO | claimed |
| US-12617761-B2 | Process for producing hexahydro 1,3,5-trinitro-1,3,5-triazine and octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine | PHILLIPS JAMES E (US) | 2026-05-05 | — | — | US | disclosed |
| EP-4073062-B1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | RYVU THERAPEUTICS S A (PL) | 2026-04-29 | — | — | EP | disclosed |
| US-12595238-B2 | Process for producing hexahydro 1,3,5-trinitro-1,3,5-triazine and octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine | PHILLIPS JAMES E (US) | 2026-04-07 | — | — | US | disclosed |
| EP-1117667-B1 | BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2007-05-30 | — | — | EP | disclosed |
| EP-1119570-B1 | TRICYCLIC DELTA3-PIPERIDINES AS PHARMACEUTICALS | JANSSEN PHARMACEUTICA NV (BE) | 2004-06-16 | — | — | EP | disclosed |
| US-6576640-B1 | Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-06-10 | — | — | US | disclosed |
| EP-0160148-A1 | Process for the hydroxylation of olefins using molecular oxygen, an osmium containing catalyst, a copper cocatalyst, and a cycloaliphatic amine based promoter | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1985-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190015388-A1 | COMPOSITIONS COMPRISING CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | SMCHD1, ALDH1A2, CRYAB | HIF1A 916/4885MAPT 1897/4885PDE4A 2253/4885 |
| US-10105350-B2 | Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking agents | COL1A1, COL14A1, COL2A1 | HIF1A 859/4885MAPT 2942/4885PDE4A 1264/4885 |
| US-20200138787-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | ALDH1A2, FAAH, FAAH2 | HIF1A 928/4885MAPT 2156/4885PDE4A 1404/4885 |
| US-10292967-B2 | Compositions comprising corneoscleral tissue cross-linking agents | SMCHD1, ALDH1A2, CRYAB | HIF1A 916/4885MAPT 1897/4885PDE4A 2253/4885 |
| US-20160374992-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | COL1A1, COL14A1, COL2A1 | HIF1A 859/4885MAPT 2942/4885PDE4A 1264/4885 |
| US-12595238-B2 | Process for producing hexahydro 1,3,5-trinitro-1,3,5-triazine and octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine | HAO2, TDO2, NT5C | HIF1A 147/4885MAPT 2680/4885PDE4A 2439/4885 |
| US-12617761-B2 | Process for producing hexahydro 1,3,5-trinitro-1,3,5-triazine and octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine | NT5C, TDO2, TH | HIF1A 219/4885MAPT 3034/4885PDE4A 2550/4885 |
| US-20120046246-A1 | METHODS FOR TREATING OSTEOCLAST-RELATED DISEASE, COMPOUNDS AND COMPOSITIONS THEREOF | CTSB, SOST, CTSG | HIF1A 159/4885MAPT 3657/4885PDE4A 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.